Alberta Investment Management Corp (AIMCo)’s Akebia Therapeutics AKBA Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio AKBA Stock Details AKBA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-54,100	Closed	-$443K	–	910
2019 Q1	$443K	Buy	54,100 +14,600	+37%	+$100K	﹤0.01%	769
2018 Q4	$218K	Buy	+39,500	New	+$309K	﹤0.01%	762
2018 Q3	–	Sell	-52,000	Closed	-$519K	–	779
2018 Q2	$519K	Sell	52,000 -26,900	-34%	-$269K	﹤0.01%	702
2018 Q1	$752K	Buy	78,900 +35,600	+82%	+$498K	0.01%	635
2017 Q4	$644K	Buy	+43,300	New	+$718K	0.01%	612

Other funds holding AKBA

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s AKBA Position: Q2 2019 in Review

Alberta Investment Management Corp (AIMCo) sold out of Akebia Therapeutics (AKBA) in Q2 2019, closing a stake of 54,100 shares — an estimated $443K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in AKBA in Q4 2017 and held it in 5 quarters. The position peaked at $752K in Q1 2018. 151 funds tracked by Wall St. Rank hold AKBA as of Q2 2019.

Alberta Investment Management Corp (AIMCo) reported no remaining Akebia Therapeutics position as of Q2 2019 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 54,100 Akebia Therapeutics shares in Q2 2019, an estimated $443K.
Alberta Investment Management Corp (AIMCo) first reported a position in Akebia Therapeutics in Q4 2017 and held it in 5 quarters.
Alberta Investment Management Corp (AIMCo)'s Akebia Therapeutics position peaked at $752K in Q1 2018.
151 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2019.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2019, filed 14 Aug 2019.